FDA Pharmaceutical Approval: Glassia

August 12, 2010

Kamada Ltd. (KMDA.TA) received FDA Approval for AATD Drug Glassia. According to the Alpha-1 Association, Alpha-1 Antitrypsin Deficiency (Alpha-1) is a condition that is passed on from parents to their children through genes. This condition may result in serious lung and/or liver disease at various ages in life. Alpha-1 antitrypsin is a protein that is […]

Continue Reading

FDA Pharmaceutical Approval: Zuplenz

August 10, 2010

FDA Approves Strativa Pharmaceuticals’ Zuplenz (ondansetron) Oral Soluble Film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. “The FDA approval of Zuplenz marks an important milestone for Strativa as it reinforces our commitment to enhancing prescription products to meet the different needs of patients,” said John A. […]

Continue Reading

Happy Birthday BOTOX!

March 31, 2010

  While the results are temporary, I have a feeling BOTOX® is here to stay. Did you know BOTOX is the most popular non-surgical beauty treatment in the world? It is also one of the world’s most versatile and most widely researched medicines in the world. Botulinum toxin, a purified protein derived from the bacterium […]

Continue Reading

Theravance and Astellas Announce FDA Approval of VIBATIV(TM) (telavancin)

September 15, 2009

Vibativ was recently approved by the FDA for the treatment of complicated skin and skin structure infections. “We are very pleased with the FDA’s approval of VIBATIV, and extremely excited about the prospect of bringing this new medicine to the market,” said Rick E Winningham, Theravance’s Chief Executive Officer. “This is a significant event that […]

Continue Reading